CSIGN COVID surveillance intensification in Ghana Network

  • Funded by European & Developing Countries Clinical Trials Partnership (EDCTP)
  • Total publications:0 publications

Grant number: RIA2020EF-2983

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2020
  • Known Financial Commitments (USD)

    $594,426.42
  • Funder

    European & Developing Countries Clinical Trials Partnership (EDCTP)
  • Principal Investigator

    Dr. Michael Marks
  • Research Location

    Ghana
  • Lead Research Institution

    London School of Hygiene & Tropical Medicine
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The CSIGN project (RIA2020EF-2983) aims to build the Ghana COVID-19 surveillance and response system, by amplifying and redirecting the already excellent influenza surveillance toward the new pathogen, by enhancing response activities through contact tracing, and by building capacity in laboratory testing and sequencing.